Speaker(s)

Professor and Group Leader, John Innes Centre

Plant Scientist, Rothamsted Research

VP & General Manager, UK & Ireland, Alexion, AstraZeneca Rare Disease

CEO & Chief Scientist, Lir Therapeutics

Head of Computational Biology, DISCO Pharmaceuticals

Principal Scientist, Quotient Therapeutics

Programme Director, Commercial, Managed Access and Medicines Policy, NICE

Managing Director, CGT Incubator, Bayer

Director, AI for Science, GSK

Clinical Psychologist, Royal Free London NHS Foundation Trust